NCT05998447 2025-12-16GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract CancerGenome & CompanyPhase 2 Terminated10 enrolled
NCT04234113 2025-01-08Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled